OAR 855-045-0240
Labeling

In addition to the labeling requirements specified in Division 041, the label of a compounded drug dispensed or distributed must contain the following, at a minimum:
(1) The generic or official name of each active ingredient;
(2) The strength or concentration of each active ingredient, to include primary solution for a sterile parenteral preparation;
(3) The dosage form and route of administration;
(4) Rate of infusion, for a sterile parenteral preparation;
(5) The total quantity of the drug product;
(6) A BUD, compliant with current USP standards; and
(7) Handling, storage or drug specific instructions, cautionary information, and warnings as necessary or appropriate for proper use and patient safety.

Source: Rule 855-045-0240 — Labeling, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=855-045-0240 (accessed May 26, 2025).

May 26, 2025

Rule 855-045-0240's source at or​.us